B
Bone Biologics Corp Common StockBBLG
Bone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking work with select strategic partners that builds on the preclinical research of the NELL-1 protein. Bone Biologics is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis.
US StocksSmall CapHealthcare
BBLG の価格トレンド
Bone Biologics Corp Common Stock · TradingView フルチャート
NASDAQ:BBLG